{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:31:28Z","timestamp":1789072288435,"version":"build-2803163510"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T00:00:00Z","timestamp":1683331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.biopha.2023.114861","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:49:06Z","timestamp":1683762546000},"page":"114861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Transient Receptor Potential Vanilloid (TRPV4) channel inhibition: A novel promising approach for the treatment of lung diseases"],"prefix":"10.1016","volume":"163","author":[{"given":"Mohit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Kamaruz","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danswrang","family":"Goyary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manash Pratim","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pronobesh","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.114861_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: Diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.biopha.2023.114861_bib2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1053\/j.jvca.2018.08.002","article-title":"Frailty in the end-stage lung disease or heart failure patient: implications for the perioperative transplant clinician","volume":"33","author":"Bottiger","year":"2019","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.biopha.2023.114861_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thoraxjnl-2012-201945","article-title":"Association between \u03b2-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension","volume":"67","author":"Stefan","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.biopha.2023.114861_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2023.114861_bib5","first-page":"12","article-title":"Modulators of transient receptor potential (TRP) channels as therapeutic options in lung disease","author":"Dietrich","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2023.114861_bib6","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.0c01303","article-title":"Design and OPtimization of an Acyclic Amine Series of TRPV4 antagonists by electronic modulation of hydrogen bond interactions","author":"Patterson","year":"2020","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib7","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1021\/acs.jmedchem.8b01615","article-title":"Discovery of novel transient receptor potential vanilloid 4 (TRPV4) agonists as regulators of chondrogenic differentiation: identification of quinazolin-4(3H)-ones and in vivo studies on a surgically induced rat model of osteoarthritis","volume":"62","author":"Atobe","year":"2019","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pbiomolbio.2009.10.002","article-title":"The vanilloid transient receptor potential channel TRPV4: from structure to disease","volume":"103","author":"Everaerts","year":"2010","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114861_bib9","first-page":"21","article-title":"TRPV4: a physio and pathophysiologically significant ion channel","author":"Rosenbaum","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114861_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41374-019-0305-y","article-title":"TRPV4 is dispensable for the development of airway allergic asthma","volume":"100","author":"Palaniyandi","year":"2020","journal-title":"Lab Invest."},{"key":"10.1016\/j.biopha.2023.114861_bib11","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000247065.11756.19","article-title":"Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury","volume":"99","author":"Alvarez","year":"2006","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114861_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000247065.11756.19","article-title":"Transient receptor potential vanilloid 4\u2013mediated disruption of the alveolar septal barrier","volume":"99","author":"Alvarez","year":"2006","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114861_bib13","doi-asserted-by":"crossref","first-page":"L817","DOI":"10.1152\/ajplung.00254.2014","article-title":"TRPV4: An exciting new target to promote alveolocapillary barrier function","volume":"307","author":"Morty","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2500\/ajr.2008.22.3125","article-title":"Transient receptor potential vanilloid type 4 channel expression in chronic rhinosinusitis","volume":"22","author":"Bhargave","year":"2008","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.biopha.2023.114861_bib15","first-page":"302","article-title":"Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension","author":"Yang","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib16","doi-asserted-by":"crossref","first-page":"32037","DOI":"10.1074\/jbc.M303251200","article-title":"Warm temperatures activate TRPV4 in mouse 308 keratinocytes","volume":"278","author":"Chung","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib17","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.0803970105","article-title":"TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells","volume":"105","author":"Lorenzo","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.114861_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2019.00093","article-title":"Thin air, thick vessels: historical and current perspectives on hypoxic pulmonary hypertension","volume":"6","author":"Young","year":"2019","journal-title":"Front Med"},{"key":"10.1016\/j.biopha.2023.114861_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","article-title":"Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine","volume":"151","author":"Dunham-Snary","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2023.114861_bib20","doi-asserted-by":"crossref","first-page":"L269","DOI":"10.1152\/ajplung.00153.2004","article-title":"A possible role for TRPV4 receptors in asthma","volume":"287","author":"Liedtke","year":"2004","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib21","doi-asserted-by":"crossref","first-page":"54062","DOI":"10.1074\/jbc.M409708200","article-title":"Swelling-activated Ca2+ entry via TRPV4 channel is defective in cystic fibrosis airway epithelia","volume":"279","author":"Arniges","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chest.2016.09.001","article-title":"Hypoxic pulmonary vasoconstriction: from molecular mechanisms to medicine","volume":"151","author":"Dunham-Snary","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2023.114861_bib23","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/hmg\/ddp111","article-title":"Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease","volume":"18","author":"Zhu","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2023.114861_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21113837","article-title":"Trpv4: A physio and pathophysiologically significant ion channel","volume":"21","author":"Rosenbaum","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.114861_bib25","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pbiomolbio.2009.10.002","article-title":"The vanilloid transient receptor potential channel TRPV4: From structure to disease","volume":"103","author":"Everaerts","year":"2010","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114861_bib26","article-title":"Role of transient receptor potential vanilloid 4 in vascular function","volume":"8","author":"Liu","year":"2021","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.biopha.2023.114861_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134464","article-title":"TRPV4 channels are essential for alveolar epithelial barrier function as protection from lung edema","volume":"5","author":"Weber","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.114861_bib28","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hep.29577","article-title":"Cholangiocyte autophagy contributes to hepatic cystogenesis in polycystic liver disease and represents a potential therapeutic target","volume":"67","author":"Masyuk","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.114861_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ceca.2008.01.008","article-title":"Dependence of regulatory volume decrease on transient receptor potential vanilloid 4 (TRPV4) expression in human corneal epithelial cells","volume":"44","author":"Pan","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.biopha.2023.114861_bib30","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00125-008-1111-z","article-title":"Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4","volume":"51","author":"Casas","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2023.114861_bib31","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/jm9001007","article-title":"Modulation of the transient receptor potential vanilloid channel TRPV4 by 4\u03b1-phorbol esters: A structure-activity study","volume":"52","author":"Klausen","year":"2009","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib32","series-title":"Small Molecule Agonists and Antagonists of TRPV4","author":"Duncton","year":"2015"},{"key":"10.1016\/j.biopha.2023.114861_bib33","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1021\/acs.jmedchem.9b01247","article-title":"Discovery of GSK3527497: A candidate for the inhibition of transient receptor potential vanilloid-4 (TRPV4)","volume":"62","author":"Brooks","year":"2019","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib34","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1021\/acs.jmedchem.8b01344","article-title":"Design and optimization of sulfone pyrrolidine sulfonamide antagonists of transient receptor potential vanilloid-4 with in vivo activity in a pulmonary edema model","volume":"61","author":"Pero","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/ml300449k","article-title":"Optimization of a novel series of TRPV4 antagonists with in vivo activity in a model of pulmonary edema","volume":"4","author":"Hilfiker","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114861_bib36","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acsmedchemlett.9b00274","article-title":"Discovery of GSK2798745: a clinical candidate for inhibition of transient receptor potential vanilloid 4 (TRPV4)","volume":"10","author":"Brooks","year":"2019","journal-title":"ACS Med Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114861_bib37","doi-asserted-by":"crossref","first-page":"9738","DOI":"10.1021\/acs.jmedchem.8b01317","article-title":"Discovery of pyrrolidine sulfonamides as selective and orally bioavailable antagonists of transient receptor potential vanilloid-4 (TRPV4)","volume":"61","author":"Brnardic","year":"2018","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib38","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1152\/ajplung.00244.2011","article-title":"Implication of the ryanodine receptor in TRPV4-induced calcium response in pulmonary arterial smooth muscle cells from normoxic and chronically hypoxic rats","volume":"303","author":"Dahan","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib39","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1152\/ajpcell.00010.2012","article-title":"TRPV4 in porcine lens epithelium regulates hemichannel-mediated ATP release and Na-K-ATPase activity","volume":"302","author":"Shahidullah","year":"2012","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1152\/physrev.00026.2014","article-title":"Transient receptor potential channels in the vasculature","volume":"95","author":"Earley","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2023.114861_bib41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/ALN.0000000000000647","article-title":"TRPV4 is required for hypoxic pulmonary vasoconstriction","volume":"122","author":"Goldenberg","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopha.2023.114861_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1152\/ajplung.00065.2014","article-title":"TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury","volume":"307","author":"Balakrishna","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib43","doi-asserted-by":"crossref","first-page":"C195","DOI":"10.1152\/ajpcell.00365.2003","article-title":"TRPV4 calcium entry channel: a paradigm for gating diversity","volume":"286","author":"Nilius","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib44","doi-asserted-by":"crossref","first-page":"33704","DOI":"10.1074\/jbc.M204828200","article-title":"Molecular determinants of permeation through the cation channel TRPV4","volume":"277","author":"Voets","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1476-5381.2011.01767.x","article-title":"Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel","volume":"166","author":"Ma","year":"2012","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114861_bib46","doi-asserted-by":"crossref","first-page":"18753","DOI":"10.1074\/jbc.M602452200","article-title":"PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the subcellular localization of TRPV4","volume":"281","author":"Cuajungco","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib47","doi-asserted-by":"crossref","first-page":"51448","DOI":"10.1074\/jbc.M308212200","article-title":"Microtubule-associated [corrected] protein 7 increases the membrane expression of transient receptor potential vanilloid 4 (TRPV4)","volume":"278","author":"Suzuki","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejcb.2008.10.002","article-title":"Functional interaction of the cation channel transient receptor potential vanilloid 4 (TRPV4) and actin in volume regulation","volume":"88","author":"Becker","year":"2009","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.114861_bib49","doi-asserted-by":"crossref","first-page":"15485","DOI":"10.1074\/jbc.M600549200","article-title":"A role for AQP5 in activation of TRPV4 by hypotonicity: concerted involvement of AQP5 and TRPV4 in regulation of cell volume recovery","volume":"281","author":"Liu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib50","doi-asserted-by":"crossref","first-page":"15689","DOI":"10.1523\/JNEUROSCI.2540-14.2014","article-title":"Swelling and eicosanoid metabolites differentially gate TRPV4 channels in retinal neurons and glia","volume":"34","author":"Ryskamp","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2023.114861_bib51","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/01.RES.0000194321.60300.d6","article-title":"TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels","volume":"97","author":"Earley","year":"2005","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114861_bib52","doi-asserted-by":"crossref","first-page":"36561","DOI":"10.1074\/jbc.M703903200","article-title":"OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physiolgenomics.2001.4.3.165","article-title":"Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2","volume":"4","author":"Delany","year":"2001","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.biopha.2023.114861_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s12195-018-0538-7","article-title":"The mechanosensitive ion channel TRPV4 is a regulator of lung development and pulmonary vasculature stabilization","volume":"11","author":"Morgan","year":"2018","journal-title":"Cell Mol. Bioeng."},{"key":"10.1016\/j.biopha.2023.114861_bib55","doi-asserted-by":"crossref","first-page":"12611","DOI":"10.1073\/pnas.0803970105","article-title":"TRPV4 channel participates in receptor-operated calcium entry and ciliary beat frequency regulation in mouse airway epithelial cells","volume":"105","author":"Lorenzo","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.114861_bib56","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00418-018-1747-9","article-title":"The micromechanics of lung alveoli: structure and function of surfactant and tissue components","volume":"150","author":"Knudsen","year":"2018","journal-title":"Histochem Cell Biol."},{"key":"10.1016\/j.biopha.2023.114861_bib57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1164\/arrd.1977.116.4.589","article-title":"Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with Septicemia","volume":"116","author":"Bachofen","year":"1977","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.biopha.2023.114861_bib58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2023.114861_bib59","doi-asserted-by":"crossref","first-page":"L893","DOI":"10.1152\/ajplung.00430.2017","article-title":"Reactive oxygen species induced Ca(2+) influx via TRPV4 and microvascular endothelial dysfunction in the SU5416\/hypoxia model of pulmonary arterial hypertension","volume":"314","author":"Suresh","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib60","doi-asserted-by":"crossref","first-page":"L1467","DOI":"10.1152\/ajplung.00275.2015","article-title":"Hydrogen peroxide-induced calcium influx in lung microvascular endothelial cells involves TRPV4","volume":"309","author":"Suresh","year":"2015","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00620","article-title":"Mast cell: a multi-functional master cell","volume":"6","author":"Krystel-Whittemore","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.114861_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1152\/physrev.00041.2010","article-title":"Hypoxic pulmonary vasoconstriction","volume":"92","author":"Sylvester","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2023.114861_bib63","first-page":"4306","article-title":"Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response","volume":"22","author":"Keser\u00fc","year":"2008","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.biopha.2023.114861_bib64","doi-asserted-by":"crossref","first-page":"18174","DOI":"10.1073\/pnas.1211946109","article-title":"Low intravascular pressure activates endothelial cell TRPV4 channels, local Ca2+ events, and IKCa channels, reducing arteriolar tone","volume":"109","author":"Bagher","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.114861_bib65","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(11)60052-4","article-title":"Idiopathic pulmonary fibrosis","volume":"378","author":"King","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.114861_bib66","doi-asserted-by":"crossref","first-page":"L86","DOI":"10.1152\/ajplung.00331.2009","article-title":"Alpha1G T-type calcium channel selectively regulates P-selectin surface expression in pulmonary capillary endothelium","volume":"299","author":"Zhou","year":"2010","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib67","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1152\/ajplung.00015.2009","article-title":"Ca2+ entry via \u03b11G and TRPV4 channels differentially regulates surface expression of P-selectin and barrier integrity in pulmonary capillary endothelium","volume":"297","author":"Wu","year":"2009","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib68","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/hmg\/ddp111","article-title":"Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease","volume":"18","author":"Zhu","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2023.114861_bib69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1164\/rccm.201302-0302OC","article-title":"Regulation of hypoxia-induced pulmonary hypertension by vascular smooth muscle hypoxia-inducible factor-1\u03b1","volume":"189","author":"Ball","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.biopha.2023.114861_bib70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00424-015-1704-6","article-title":"Effect of hypoxia on TRPV1 and TRPV4 channels in rat pulmonary arterial smooth muscle cells","volume":"468","author":"Parpaite","year":"2016","journal-title":"Pflug. Arch."},{"key":"10.1016\/j.biopha.2023.114861_bib71","doi-asserted-by":"crossref","first-page":"L555","DOI":"10.1152\/ajplung.00005.2011","article-title":"Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension","volume":"302","author":"Yang","year":"2012","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib72","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00210-014-1058-1","article-title":"TRPV4: Physiological role and therapeutic potential in respiratory diseases","volume":"388","author":"Goldenberg","year":"2015","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2023.114861_bib73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00210-014-1058-1","article-title":"TRPV4: physiological role and therapeutic potential in respiratory diseases","volume":"388","author":"Goldenberg","year":"2015","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2023.114861_bib74","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41467-017-01201-3","article-title":"TRPV4 activation triggers protective responses to bacterial lipopolysaccharides in airway epithelial cells","volume":"8","author":"Alpizar","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.114861_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1378\/chest.08-2572","article-title":"Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia","volume":"136","author":"Song","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.biopha.2023.114861_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008959","article-title":"CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis","volume":"5","author":"Gilani","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114861_bib77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-134-2-200101160-00015","article-title":"Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy","volume":"134","author":"Selman","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2023.114861_bib78","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1172\/JCI75331","article-title":"TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice","volume":"124","author":"Rahaman","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.biopha.2023.114861_bib79","first-page":"197","article-title":"Acute lung injury: the injured lung endothelium, therapeutic strategies for barrier protection, and vascular biomarkers","author":"Chiang","year":"2010","journal-title":"Textb Pulm Vasc. Dis."},{"key":"10.1016\/j.biopha.2023.114861_bib80","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53072","article-title":"Defining the role of pulmonary endothelial cell heterogeneity in the response to acute lung injury","volume":"9","author":"Niethamer","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.biopha.2023.114861_bib81","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1165\/rcmb.2007-0192OC","article-title":"High vascular pressure-induced lung injury requires P450 epoxygenase-dependent activation of TRPV4","volume":"38","author":"Jian","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2023.114861_bib82","doi-asserted-by":"crossref","first-page":"L158","DOI":"10.1152\/ajplung.00065.2014","article-title":"TRPV4 inhibition counteracts edema and inflammation and improves pulmonary function and oxygen saturation in chemically induced acute lung injury","volume":"307","author":"Balakrishna","year":"2014","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib83","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.athoracsur.2021.04.052","article-title":"Endothelial transient receptor potential vanilloid 4 channels mediate lung ischemia-reperfusion injury","volume":"113","author":"Haywood","year":"2022","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.biopha.2023.114861_bib84","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.4049\/jimmunol.1901033","article-title":"TRPV4 protects the lung from bacterial pneumonia via MAPK molecular pathway switching","volume":"204","author":"Scheraga","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2023.114861_bib85","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJMra1608969","article-title":"Severe and difficult-to-treat asthma in adults","volume":"377","author":"Israel","year":"2017","journal-title":"New Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.114861_bib86","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ni1558","article-title":"A mechanism for the initiation of allergen-induced T helper type 2 responses","volume":"9","author":"Sokol","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2023.114861_bib87","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114861_bib88","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41374-019-0305-y","article-title":"TRPV4 is dispensable for the development of airway allergic asthma","volume":"100","author":"Palaniyandi","year":"2020","journal-title":"Lab Invest."},{"key":"10.1016\/j.biopha.2023.114861_bib89","doi-asserted-by":"crossref","first-page":"L664","DOI":"10.1152\/ajplung.00442.2015","article-title":"In vitro and in vivo evidence for an inflammatory role of the calcium channel TRPV4 in lung epithelium: Potential involvement in cystic fibrosis","volume":"311","author":"Henry","year":"2016","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCRESAHA.115.301146","article-title":"Pulmonary arterial hypertension: the clinical syndrome","volume":"115","author":"Lai","year":"2014","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114861_bib91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2023.114861_bib92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00424-015-1704-6","article-title":"Effect of hypoxia on TRPV1 and TRPV4 channels in rat pulmonary arterial smooth muscle cells","volume":"468","author":"Parpaite","year":"2016","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"10.1016\/j.biopha.2023.114861_bib93","first-page":"118","article-title":"Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension","author":"Daneva","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.114861_bib94","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.332.7551.1202","article-title":"Pathology, pathogenesis, and pathophysiology","volume":"332","author":"MacNee","year":"2006","journal-title":"BMJ Br. Med J."},{"key":"10.1016\/j.biopha.2023.114861_bib95","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.biopha.2023.114861_bib96","first-page":"10","article-title":"Calcium-dependent pulmonary inflammation and pharmacological interventions and mediators","author":"Shipman","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.biopha.2023.114861_bib97","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/19336950.2015.1075105","article-title":"Ion channel therapeutics for pain","volume":"9","author":"Skerratt","year":"2015","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.biopha.2023.114861_bib98","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1517\/13543776.2010.513384","article-title":"Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy","volume":"20","author":"Castle","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.biopha.2023.114861_bib99","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000247065.11756.19","article-title":"Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: A novel mechanism of acute lung injury","volume":"99","author":"Alvarez","year":"2006","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.114861_bib100","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1074\/jbc.M200062200","article-title":"Activation of TRPV4 channels (hVRL-2\/mTRP12) by phorbol derivatives","volume":"277","author":"Watanabe","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib101","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbrc.2009.09.007","article-title":"Identification and characterization of novel TRPV4 modulators","volume":"389","author":"Vincent","year":"2009","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2023.114861_bib102","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/jm9001007","article-title":"Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study","volume":"52","author":"Klausen","year":"2009","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2023.114861_bib103","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1124\/jpet.108.139295","article-title":"N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urin","volume":"326","author":"Thorneloe","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114861_bib104","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.107.134551","article-title":"Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2","volume":"326","author":"Willette","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114861_bib105","doi-asserted-by":"crossref","first-page":"29897","DOI":"10.1074\/jbc.M605394200","article-title":"Bisandrographolide from Andrographis paniculata activates TRPV4 channels","volume":"281","author":"Smith","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Suppl:","key":"10.1016\/j.biopha.2023.114861_bib106","first-page":"S1","article-title":"Guide to receptors and channels (GRAC), 3rd edition","volume":"153","author":"Alexander","year":"2008","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114861_bib107","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0022-3565(24)38291-6","article-title":"Block by ruthenium red of cloned neuronal voltage-gated calcium channels","volume":"289","author":"Cibulsky","year":"1999","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.114861_bib108","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1161\/CIRCULATIONAHA.108.835389","article-title":"Regulation of the human cardiac mitochondrial Ca 2+ uptake by 2 different voltage-gated Ca 2+ channels","volume":"119","author":"Michels","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.114861_bib109","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbrc.2009.09.007","article-title":"Identification and characterization of novel TRPV4 modulators","volume":"389","author":"Vincent","year":"2009","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2023.114861_bib110","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/6ba8e9d9-0035-405e-a7c7-45ee22b2e381","article-title":"Citral sensing by Transient [corrected] receptor potential channels in dorsal root ganglion neurons","volume":"3","author":"Stotz","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114861_bib111","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1002\/art.24799","article-title":"Functional characterization of TRPV4 as an osmotically sensitive ion channel in porcine articular chondrocytes","volume":"60","author":"Phan","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2023.114861_bib112","doi-asserted-by":"crossref","first-page":"19084","DOI":"10.1073\/pnas.1005333107","article-title":"Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis","volume":"107","author":"Everaerts","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2023.114861_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172408","article-title":"The selective TRPV4 channel antagonist HC-067047 attenuates mechanical allodynia in diabetic mice","volume":"856","author":"Dias","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114861_bib114","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bph.12315","article-title":"Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer\u2019s disease","volume":"170","author":"Zhang","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.114861_bib115","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cns.12143","article-title":"Transient receptor potential vanilloid 4 mediates hypotonicity-induced enhancement of synaptic transmission in hippocampal slices","volume":"19","author":"Li","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.biopha.2023.114861_bib116","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1021\/acsmedchemlett.7b00094","article-title":"Discovery of GSK2193874: an orally active, potent, and selective blocker of transient receptor potential vanilloid 4","volume":"8","author":"Cheung","year":"2017","journal-title":"ACS Med Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114861_bib117","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1016\/j.bmcl.2015.06.098","article-title":"Identification of orally-bioavailable antagonists of the TRPV4 ion-channel","volume":"25","author":"Wei","year":"2015","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2023.114861_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004276","article-title":"An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure","volume":"4","author":"Thorneloe","year":"2012","journal-title":"Sci. Transl. Med"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223006510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223006510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:36:43Z","timestamp":1780335403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223006510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":118,"alternative-id":["S0753332223006510"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114861","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient Receptor Potential Vanilloid (TRPV4) channel inhibition: A novel promising approach for the treatment of lung diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114861"}}